Loading…

Synthesis and in silico study of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives as suitable therapeutic agents

In the study presented here, a new series of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives was targeted. The synthesis was initiated by the treatment of different secondary amines (1a-h) with 4-bromomethylbenzenesulfonyl chloride (2) to obtain various 1-{[4-(bromome...

Full description

Saved in:
Bibliographic Details
Published in:Brazilian Journal of Pharmaceutical Sciences 2017-01, Vol.53 (1)
Main Authors: Hussain, Ghulam, Abbasi, Muhammad Athar, Aziz-ur-Rehman, Siddiqui, Sabahat Zahra, Shah, Syed Adnan Ali, Ashraf, Muhammad, Qurat-ul-Ain, Ahmad, Irshad, Malik, Rabia, Lodhi, Muhammad Arif, Khan, Farman Ali, Shahid, Muhammad, Fatima, Hina
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c439t-8759d1ac41a1dd995015cce4be31e09feeee69694d04ca5ef2d4c49a59d009153
cites cdi_FETCH-LOGICAL-c439t-8759d1ac41a1dd995015cce4be31e09feeee69694d04ca5ef2d4c49a59d009153
container_end_page
container_issue 1
container_start_page
container_title Brazilian Journal of Pharmaceutical Sciences
container_volume 53
creator Hussain, Ghulam
Abbasi, Muhammad Athar
Aziz-ur-Rehman
Siddiqui, Sabahat Zahra
Shah, Syed Adnan Ali
Ashraf, Muhammad
Qurat-ul-Ain
Ahmad, Irshad
Malik, Rabia
Lodhi, Muhammad Arif
Khan, Farman Ali
Shahid, Muhammad
Fatima, Hina
description In the study presented here, a new series of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives was targeted. The synthesis was initiated by the treatment of different secondary amines (1a-h) with 4-bromomethylbenzenesulfonyl chloride (2) to obtain various 1-{[4-(bromomethyl)phenyl]sulfonyl}amines (3a-h). 2-Furyl(1-piperazinyl)methanone (2-furoyl-1-piperazine; 4) was then dissolved in acetonitrile, with the addition of K2CO3, and the mixture was refluxed for activation. This activated molecule was further treated with equi-molar amounts of 3a-h to form targeted 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives (5a-h) in the same reaction set up. The structure confirmation of all the synthesized compounds was carried out by EI-MS, IR and 1H-NMR spectral analysis. The compounds showed good enzyme inhibitory activity. Compound 5h showed excellent inhibitory effect against acetyl- and butyrylcholinesterase with respective IC50 values of 2.91±0.001 and 4.35±0.004 μM, compared to eserine, a reference standard with IC50 values of 0.04±0.0001 and 0.85±0.001 μM, respectively, against these enzymes. All synthesized molecules were active against almost all Gram-positive and Gram-negative bacterial strains tested. The cytotoxicity of the molecules was also checked to determine their utility as possible therapeutic agents.
doi_str_mv 10.1590/s2175-97902017000115237
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7203421d4d0440c2bd1dd60565a445b2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S1984_82502017000100613</scielo_id><doaj_id>oai_doaj_org_article_7203421d4d0440c2bd1dd60565a445b2</doaj_id><sourcerecordid>2484256564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-8759d1ac41a1dd995015cce4be31e09feeee69694d04ca5ef2d4c49a59d009153</originalsourceid><addsrcrecordid>eNplUV1r1jAULqLg2PYbDHizXWQm6UnbXMrQORjsYnolEtLkdMtL19QkHXTib_Avm-71C8xNwuH5ynmq6hVnZ1wq9iYJ3kqqWsUE4y1jjHMp6vZZdcBVB7QTkj3_5_2yOk5pt8EkdArkQfXjZp3yHSafiJkc8RNJfvQ2kJQXt5IwEEGHJa7jCdBvQD-fpKVP2ecloztNyziEaR2_9Dg9ruN3yunsZ4zm0Zfp6T3mOzOFCYnD6B9M9g9YbBJJi8-mH5EU52hmXLK3xNzilNNR9WIwY8LjX_dh9en9u4_nH-jV9cXl-dsraqFWmXatVI4bC9xw55SS5UfWIvRYc2RqwHIa1ShwDKyROAgHFpQpLMYUl_VhdbnXdcHs9Bz9vYmrDsbrp0GIt9rEEmtE3QpWg-Bu0wJmRe-KZcNkIw2A7EXROttrJetxDHoXljiV8PpmW7zeFv-7HcYaXhfC6z1hjuHrgin_pQjoQBTpBgqq3aNsDClFHP7E5Exv7eun9vV_7dc_AWEJogM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2484256564</pqid></control><display><type>article</type><title>Synthesis and in silico study of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives as suitable therapeutic agents</title><source>Publicly Available Content Database</source><source>SciELO</source><creator>Hussain, Ghulam ; Abbasi, Muhammad Athar ; Aziz-ur-Rehman ; Siddiqui, Sabahat Zahra ; Shah, Syed Adnan Ali ; Ashraf, Muhammad ; Qurat-ul-Ain ; Ahmad, Irshad ; Malik, Rabia ; Lodhi, Muhammad Arif ; Khan, Farman Ali ; Shahid, Muhammad ; Fatima, Hina</creator><creatorcontrib>Hussain, Ghulam ; Abbasi, Muhammad Athar ; Aziz-ur-Rehman ; Siddiqui, Sabahat Zahra ; Shah, Syed Adnan Ali ; Ashraf, Muhammad ; Qurat-ul-Ain ; Ahmad, Irshad ; Malik, Rabia ; Lodhi, Muhammad Arif ; Khan, Farman Ali ; Shahid, Muhammad ; Fatima, Hina</creatorcontrib><description>In the study presented here, a new series of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives was targeted. The synthesis was initiated by the treatment of different secondary amines (1a-h) with 4-bromomethylbenzenesulfonyl chloride (2) to obtain various 1-{[4-(bromomethyl)phenyl]sulfonyl}amines (3a-h). 2-Furyl(1-piperazinyl)methanone (2-furoyl-1-piperazine; 4) was then dissolved in acetonitrile, with the addition of K2CO3, and the mixture was refluxed for activation. This activated molecule was further treated with equi-molar amounts of 3a-h to form targeted 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives (5a-h) in the same reaction set up. The structure confirmation of all the synthesized compounds was carried out by EI-MS, IR and 1H-NMR spectral analysis. The compounds showed good enzyme inhibitory activity. Compound 5h showed excellent inhibitory effect against acetyl- and butyrylcholinesterase with respective IC50 values of 2.91±0.001 and 4.35±0.004 μM, compared to eserine, a reference standard with IC50 values of 0.04±0.0001 and 0.85±0.001 μM, respectively, against these enzymes. All synthesized molecules were active against almost all Gram-positive and Gram-negative bacterial strains tested. The cytotoxicity of the molecules was also checked to determine their utility as possible therapeutic agents.</description><identifier>ISSN: 1984-8250</identifier><identifier>ISSN: 2175-9790</identifier><identifier>EISSN: 1984-8250</identifier><identifier>EISSN: 2175-9790</identifier><identifier>DOI: 10.1590/s2175-97902017000115237</identifier><language>eng</language><publisher>Sao Paulo: Universidade de Sao Paulo Faculdade de Ciencias</publisher><subject>Alzheimer's disease ; Antimicrobial agents ; Iodine ; PHARMACOLOGY &amp; PHARMACY ; Piperazine derivatives/ hemolytic activity ; Piperazine derivatives/antimicrobial activity ; Piperazine derivatives/Cholinesterase assays ; Piperazine derivatives/in silico</subject><ispartof>Brazilian Journal of Pharmaceutical Sciences, 2017-01, Vol.53 (1)</ispartof><rights>2017. This work is published under http://creativecommons.org/licenses/by/4.0/deed.en (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>This work is licensed under a Creative Commons Attribution 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-8759d1ac41a1dd995015cce4be31e09feeee69694d04ca5ef2d4c49a59d009153</citedby><cites>FETCH-LOGICAL-c439t-8759d1ac41a1dd995015cce4be31e09feeee69694d04ca5ef2d4c49a59d009153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2484256564/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2484256564?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,24150,25753,27924,27925,37012,44590,75126</link.rule.ids></links><search><creatorcontrib>Hussain, Ghulam</creatorcontrib><creatorcontrib>Abbasi, Muhammad Athar</creatorcontrib><creatorcontrib>Aziz-ur-Rehman</creatorcontrib><creatorcontrib>Siddiqui, Sabahat Zahra</creatorcontrib><creatorcontrib>Shah, Syed Adnan Ali</creatorcontrib><creatorcontrib>Ashraf, Muhammad</creatorcontrib><creatorcontrib>Qurat-ul-Ain</creatorcontrib><creatorcontrib>Ahmad, Irshad</creatorcontrib><creatorcontrib>Malik, Rabia</creatorcontrib><creatorcontrib>Lodhi, Muhammad Arif</creatorcontrib><creatorcontrib>Khan, Farman Ali</creatorcontrib><creatorcontrib>Shahid, Muhammad</creatorcontrib><creatorcontrib>Fatima, Hina</creatorcontrib><title>Synthesis and in silico study of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives as suitable therapeutic agents</title><title>Brazilian Journal of Pharmaceutical Sciences</title><addtitle>Braz. J. Pharm. Sci</addtitle><description>In the study presented here, a new series of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives was targeted. The synthesis was initiated by the treatment of different secondary amines (1a-h) with 4-bromomethylbenzenesulfonyl chloride (2) to obtain various 1-{[4-(bromomethyl)phenyl]sulfonyl}amines (3a-h). 2-Furyl(1-piperazinyl)methanone (2-furoyl-1-piperazine; 4) was then dissolved in acetonitrile, with the addition of K2CO3, and the mixture was refluxed for activation. This activated molecule was further treated with equi-molar amounts of 3a-h to form targeted 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives (5a-h) in the same reaction set up. The structure confirmation of all the synthesized compounds was carried out by EI-MS, IR and 1H-NMR spectral analysis. The compounds showed good enzyme inhibitory activity. Compound 5h showed excellent inhibitory effect against acetyl- and butyrylcholinesterase with respective IC50 values of 2.91±0.001 and 4.35±0.004 μM, compared to eserine, a reference standard with IC50 values of 0.04±0.0001 and 0.85±0.001 μM, respectively, against these enzymes. All synthesized molecules were active against almost all Gram-positive and Gram-negative bacterial strains tested. The cytotoxicity of the molecules was also checked to determine their utility as possible therapeutic agents.</description><subject>Alzheimer's disease</subject><subject>Antimicrobial agents</subject><subject>Iodine</subject><subject>PHARMACOLOGY &amp; PHARMACY</subject><subject>Piperazine derivatives/ hemolytic activity</subject><subject>Piperazine derivatives/antimicrobial activity</subject><subject>Piperazine derivatives/Cholinesterase assays</subject><subject>Piperazine derivatives/in silico</subject><issn>1984-8250</issn><issn>2175-9790</issn><issn>1984-8250</issn><issn>2175-9790</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNplUV1r1jAULqLg2PYbDHizXWQm6UnbXMrQORjsYnolEtLkdMtL19QkHXTib_Avm-71C8xNwuH5ynmq6hVnZ1wq9iYJ3kqqWsUE4y1jjHMp6vZZdcBVB7QTkj3_5_2yOk5pt8EkdArkQfXjZp3yHSafiJkc8RNJfvQ2kJQXt5IwEEGHJa7jCdBvQD-fpKVP2ecloztNyziEaR2_9Dg9ruN3yunsZ4zm0Zfp6T3mOzOFCYnD6B9M9g9YbBJJi8-mH5EU52hmXLK3xNzilNNR9WIwY8LjX_dh9en9u4_nH-jV9cXl-dsraqFWmXatVI4bC9xw55SS5UfWIvRYc2RqwHIa1ShwDKyROAgHFpQpLMYUl_VhdbnXdcHs9Bz9vYmrDsbrp0GIt9rEEmtE3QpWg-Bu0wJmRe-KZcNkIw2A7EXROttrJetxDHoXljiV8PpmW7zeFv-7HcYaXhfC6z1hjuHrgin_pQjoQBTpBgqq3aNsDClFHP7E5Exv7eun9vV_7dc_AWEJogM</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Hussain, Ghulam</creator><creator>Abbasi, Muhammad Athar</creator><creator>Aziz-ur-Rehman</creator><creator>Siddiqui, Sabahat Zahra</creator><creator>Shah, Syed Adnan Ali</creator><creator>Ashraf, Muhammad</creator><creator>Qurat-ul-Ain</creator><creator>Ahmad, Irshad</creator><creator>Malik, Rabia</creator><creator>Lodhi, Muhammad Arif</creator><creator>Khan, Farman Ali</creator><creator>Shahid, Muhammad</creator><creator>Fatima, Hina</creator><general>Universidade de Sao Paulo Faculdade de Ciencias</general><general>Universidade de São Paulo, Faculdade de Ciências Farmacêuticas</general><general>Universidade de São Paulo</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>GPN</scope><scope>DOA</scope></search><sort><creationdate>20170101</creationdate><title>Synthesis and in silico study of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives as suitable therapeutic agents</title><author>Hussain, Ghulam ; Abbasi, Muhammad Athar ; Aziz-ur-Rehman ; Siddiqui, Sabahat Zahra ; Shah, Syed Adnan Ali ; Ashraf, Muhammad ; Qurat-ul-Ain ; Ahmad, Irshad ; Malik, Rabia ; Lodhi, Muhammad Arif ; Khan, Farman Ali ; Shahid, Muhammad ; Fatima, Hina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-8759d1ac41a1dd995015cce4be31e09feeee69694d04ca5ef2d4c49a59d009153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Alzheimer's disease</topic><topic>Antimicrobial agents</topic><topic>Iodine</topic><topic>PHARMACOLOGY &amp; PHARMACY</topic><topic>Piperazine derivatives/ hemolytic activity</topic><topic>Piperazine derivatives/antimicrobial activity</topic><topic>Piperazine derivatives/Cholinesterase assays</topic><topic>Piperazine derivatives/in silico</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hussain, Ghulam</creatorcontrib><creatorcontrib>Abbasi, Muhammad Athar</creatorcontrib><creatorcontrib>Aziz-ur-Rehman</creatorcontrib><creatorcontrib>Siddiqui, Sabahat Zahra</creatorcontrib><creatorcontrib>Shah, Syed Adnan Ali</creatorcontrib><creatorcontrib>Ashraf, Muhammad</creatorcontrib><creatorcontrib>Qurat-ul-Ain</creatorcontrib><creatorcontrib>Ahmad, Irshad</creatorcontrib><creatorcontrib>Malik, Rabia</creatorcontrib><creatorcontrib>Lodhi, Muhammad Arif</creatorcontrib><creatorcontrib>Khan, Farman Ali</creatorcontrib><creatorcontrib>Shahid, Muhammad</creatorcontrib><creatorcontrib>Fatima, Hina</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SciELO</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Brazilian Journal of Pharmaceutical Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hussain, Ghulam</au><au>Abbasi, Muhammad Athar</au><au>Aziz-ur-Rehman</au><au>Siddiqui, Sabahat Zahra</au><au>Shah, Syed Adnan Ali</au><au>Ashraf, Muhammad</au><au>Qurat-ul-Ain</au><au>Ahmad, Irshad</au><au>Malik, Rabia</au><au>Lodhi, Muhammad Arif</au><au>Khan, Farman Ali</au><au>Shahid, Muhammad</au><au>Fatima, Hina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and in silico study of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives as suitable therapeutic agents</atitle><jtitle>Brazilian Journal of Pharmaceutical Sciences</jtitle><addtitle>Braz. J. Pharm. Sci</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>53</volume><issue>1</issue><issn>1984-8250</issn><issn>2175-9790</issn><eissn>1984-8250</eissn><eissn>2175-9790</eissn><abstract>In the study presented here, a new series of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives was targeted. The synthesis was initiated by the treatment of different secondary amines (1a-h) with 4-bromomethylbenzenesulfonyl chloride (2) to obtain various 1-{[4-(bromomethyl)phenyl]sulfonyl}amines (3a-h). 2-Furyl(1-piperazinyl)methanone (2-furoyl-1-piperazine; 4) was then dissolved in acetonitrile, with the addition of K2CO3, and the mixture was refluxed for activation. This activated molecule was further treated with equi-molar amounts of 3a-h to form targeted 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives (5a-h) in the same reaction set up. The structure confirmation of all the synthesized compounds was carried out by EI-MS, IR and 1H-NMR spectral analysis. The compounds showed good enzyme inhibitory activity. Compound 5h showed excellent inhibitory effect against acetyl- and butyrylcholinesterase with respective IC50 values of 2.91±0.001 and 4.35±0.004 μM, compared to eserine, a reference standard with IC50 values of 0.04±0.0001 and 0.85±0.001 μM, respectively, against these enzymes. All synthesized molecules were active against almost all Gram-positive and Gram-negative bacterial strains tested. The cytotoxicity of the molecules was also checked to determine their utility as possible therapeutic agents.</abstract><cop>Sao Paulo</cop><pub>Universidade de Sao Paulo Faculdade de Ciencias</pub><doi>10.1590/s2175-97902017000115237</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1984-8250
ispartof Brazilian Journal of Pharmaceutical Sciences, 2017-01, Vol.53 (1)
issn 1984-8250
2175-9790
1984-8250
2175-9790
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7203421d4d0440c2bd1dd60565a445b2
source Publicly Available Content Database; SciELO
subjects Alzheimer's disease
Antimicrobial agents
Iodine
PHARMACOLOGY & PHARMACY
Piperazine derivatives/ hemolytic activity
Piperazine derivatives/antimicrobial activity
Piperazine derivatives/Cholinesterase assays
Piperazine derivatives/in silico
title Synthesis and in silico study of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives as suitable therapeutic agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T17%3A21%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20in%20silico%20study%20of%202-furyl(4-%7B4-%5B(substituted)sulfonyl%5Dbenzyl%7D-1-piperazinyl)methanone%20derivatives%20as%20suitable%20therapeutic%20agents&rft.jtitle=Brazilian%20Journal%20of%20Pharmaceutical%20Sciences&rft.au=Hussain,%20Ghulam&rft.date=2017-01-01&rft.volume=53&rft.issue=1&rft.issn=1984-8250&rft.eissn=1984-8250&rft_id=info:doi/10.1590/s2175-97902017000115237&rft_dat=%3Cproquest_doaj_%3E2484256564%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c439t-8759d1ac41a1dd995015cce4be31e09feeee69694d04ca5ef2d4c49a59d009153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2484256564&rft_id=info:pmid/&rft_scielo_id=S1984_82502017000100613&rfr_iscdi=true